Modeling del(17)(p11.2p11.2) and dup(17)(p11.2p11.2) contiguous gene syndromes by chromosome engineering in mice: Phenotypic consequences of gene dosage imbalance

Molecular and Cellular Biology

Volumn 23, Issue 10, 2003, Pages 3646-3655

  Walz, Katherina ^a   Caratini Rivera, Sandra ^a   Bi, Weimin ^a   Fonseca, Patricia ^a   Mansouri, Dena L ^a   Lynch, Jennifer ^a   Vogel, Hannes ^c   Noebels, Jeffrey L ^a   Bradley, Allan ^d   Lupski, James R ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME 17P; CHROMOSOME DELETION; CHROMOSOME DELETION 17; CHROMOSOME DUPLICATION; CHROMOSOME DUPLICATION 17; CHROMOSOME REARRANGEMENT; CONTIGUOUS GENE SYNDROME; CRANIOFACIAL MALFORMATION; GENE DOSAGE; GENETIC ENGINEERING; HUMAN; MALE; MALE INFERTILITY; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; SEIZURE; SMITH MAGENIS SYNDROME; SYNDROME; SYNTENY;

ANIMALS; CHROMOSOMES; CHROMOSOMES, HUMAN, PAIR 17; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGY; GENE DELETION; GENE DOSAGE; GENE DUPLICATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GENOTYPE; HUMANS; MICE; MICE, INBRED C57BL; MODELS, GENETIC; ORGAN SIZE; PHENOTYPE; SYNDROME; TIME FACTORS;

ANIMALIA; MURINAE;

EID: 0037965627     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.10.3646-3655.2003     Document Type: Article

References (39)

1. Allanson, J. E., F. Greenberg, and A. C. M. Smith. 1999. The face of Smith-Magenis syndrome: a subjective and objective study. J. Med. Genet. 36:394-397.
2. Baldini, A., and E. A. Lindsay. 1994. Mapping human YAC clones by fluorescence in situ hybridization using Alu-PCR from single yeast colonies. Methods Mol. Biol. 33:75-84.
3. Bi, W., J. Yan, P. Stankiewicz, S. S. Park, K. Walz, C. F. Boerkoel, L. Potocki, L. G. Shaffer, K. Devriendt, M. J. Nowaczyk, K. Inoue, and J. R. Lupski. 2002. Genes in a refined Smith-Magenis syndrome critical deletion interval on chromosome 17p11.2 and the syntenic region of the mouse. Genome Res. 12:713-728.
4. Campbell, H. D., S. Fountain, I. S. McLennan, L. A. Berven, M. F. Crouch, D. A. Davy, J. A. Hooper, K. Waterford, K.-S. Chen, J. R. Lupski, B. Ledermann, I. G. Young, and K. I. Matthaei. 2002. Fliih, a gelsolin-related cytoskeletal regulator essential for early mammalian embryonic development. Mol. Cell. Biol. 22:3518-3526.
5. Chen, K.-S., P. Manian, T. Koeuth, L. Potocki, Q. Zhao, A. C. Chinault, C. C. Lee, and J. R. Lupski. 1997. Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome. Nat. Genet. 17:154-163.
6. Chen, K.-S., L. Potocki, and J. R. Lupski. 1996. The Smith-Magenis Syndrome [del(17)(p11.2)]: clinical review and molecular advances. Ment. Retard. Dev. Disabil. Res. Rev. 2:122-129.
7. Greenberg, F., V. Guzzetta, R. Montes de Oca-Luna, R. E. Magenis, A. C. Smith, S. F. Richter, I. Kondo, W. B. Dobyns, P. I. Patel, and J. R. Lupski. 1991. Molecular analysis of the Smith-Magenis syndrome: a possible contiguous-gene syndrome associated with del(17)(p11.2). Am. J. Hum. Genet. 49:1207-1218.
8. Greenberg, F., R. A. Lewis, L. Potocki, D. Glaze, J. Parke, J. Killian, M. A. Murphy, D. Williamson, F. Brown, R. Dutton, C. McCluggage, E. Friedman, M. Sulek, and J. R. Lupski. 1996. Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2). Am. J. Med. Genet. 62:247-254.
9. Inoue, K., and J. R. Lupski. 2002. Molecular mechanisms for genomic disorders. Annu. Rev. Genomics Hum. Genet. 3:199-242.
10. Jerome, L. A., and V. E. Papaioannou. 2001. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat. Genet. 27:286-291.
11. Jones, K. L. 1997. Smith's recognizable patterns of human malformation, 5th ed. W. B. Saunders Co., Philadelphia, Pa.
12. Li, W., and J. C. Wang. 1998. Mammalian DNA topoisomerase IIIα is essential in early embryogenesis. Proc. Natl. Acad. Sci. USA 95:1010-1013.
13. Lindsay, E. A., A. Botta, V. Jurecic, S. Carattini-Rivera, Y. C. Cheah, H. M. Rosenblatt, A. Bradley, and A. Baldini. 1999. Congenital heart disease in mice deficient for the DiGeorge syndrome region. Nature 401:379-383.
14. Lindsay, E. A., F. Vitelli, H. Su, M. Morishima, T. Huynh, T. Pramparo, V. Jurecic, G. Ogunrinu, H. F. Sutherland, P. J. Scambler, A. Bradley, and A. Baldini. 2001. Tbx1 haploinsufficiency in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410:97-101.
15. Liu, P., H. Zhang, A. McLellan, H. Vogel, and A. Bradley. 1998. Embryonic lethality and tumorigenesis caused by segmental aneuploidy on mouse chromosome 11. Genetics 150:1155-1168.
16. Lupski, J. R. 1998. Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits. Trends Genet. 14:417-422.
17. Matzuk, M. M., M. J. Finegold, J.-G. J. Su, A. J. W. Hsueh, and A. Bradley. 1992. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360:313-319.
18. McLeod, M. J. 1980. Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S. Teratology 22:299-301.
19. Merscher, S., B. Funke, J. A. Epstein, J. Heyer, A. Puech, M. M. Lu, R. J. Xavier, M. B. Demay, R. G. Russell, S. Factor, K. Tokooya, B. S. Jore, M. Lopez, R. K. Pandita, M. Lia, D. Carrion, H. Xu, H. Schorle, J. B. Kobler, P. Scambler, A. Wynshaw-Boris, A. I. Skoultchi, B. E. Morrow, and R. Kucherlapati. 2001. TBXI is responsible for cardiovascular defects in velocardio-facial/DiGeorge syndrome. Cell 104:619-629.
20. Mills, A. A., and A. Bradley. 2001. From mouse to man: generating megabase chromosome rearrangements. Trends Genet. 17:331-339.
21. Noebels, J. L., and R. L. Sidman. 1979. Inherited epilepsy: spike-wave and focal motor seizures in the mutant mouse tottering. Science 204:1334-1336.
22. Park, S.-S., P. Stankiewicz, W. Bi, C. Shaw, J. Lehoczky, K. Dewar, B. Birren, and J. R. Lupski. 2002. Structure and evolution of the Smith-Magenis syndrome repeat gene clusters, SMS-REPs. Genome Res. 12:729-738.
23. Potocki, L., K.-S. Chen, S. S. Park, D. E. Osterholm, M. A. Withers, V. Kimonis, A. M. Summers, W. S. Meschino, K. Anyane-Yeboa, C. D. Kashork, L. G. Shaffer, and J. R. Lupski. 2000. Molecular mechanism for duplication 17p11.2 - the homologous recombination reciprocal of the Smith-Magenis microdeletion. Nat. Genet. 24:84-87.
24. Probst, F. J., R. A. Fridell, Y. Raphael, T. L. Saunders, A. Wang, Y. Liang, R. J. Morell, J. W. Touchman, R. H. Lyons, K. Noben-Trauth, T. B. Friedman, and S. A. Camper. 1998. Correction of deafness in shaker-2 mice by an unconventional myosin in a BAC transgene. Science 280:1444-1447.
25. Ramirez-Solis, R., A. C. Davis, and A. Bradley. 1993. Gene targeting in embryonic stem cells. Methods Enzymol. 225:855-878.
26. Ramirez-Solis, R., P. Liu, and A. Bradley. 1995. Chromosome engineering in mice. Nature 378:720-724.
27. Richtsmeier, J. T., L. L. Baxter, and R. H. Reeves. 2002. Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice. Dev. Dyn. 217:137-145.
28. Shaffer, L. G., D. H. Ledbetter, and J. R. Lupski. 2001. The metabolic and molecular bases of inherited disease, 8th ed., vol. I, p. 1291-1327. The McGraw-Hill Companies, Inc., New York, N.Y.
29. Shimano, H., I. Shimomura, R. E. Hammer, J. Herz, J. L. Goldstein, M. S. Brown, and J. D. Horton. 1997. Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene. J. Clin. Investig. 100:2115-2124.
30. Smith, A. C. M., A. L. Gropman, J. E. Bailey-Wilson, O. Goker-Alpan, S. H. Elsea, J. Blancato, J. R. Lupski, and L. Potocki. 2002. Hypercholesterolemia in children with Smith-Magenis syndrome: del (17) (p11.2p11.2). Genet. Med. 4:118-125.
31. Smith, A. C. M., L. McGavran, J. Robinson, G. Waldstein, J. Macfarlane, J. Zonona, J. Reiss, M. Lahr, L. Allen, and E. Magenis. 1986. Interstitial deletion of (17)(p11.2p11.2) in nine patients. Am. J. Med. Genet. 24:393-414.
32. Stankiewicz, P., and J. R. Lupski. 2002. Genome architecture, rearrangements and genomic disorders. Trends Genet. 18:74-82.
33. Stankiewicz, P., and J. R. Lupski. 2002. Molecular-evolutionary mechanisms for genomic disorders. Curr. Opin. Genet. Dev. 1:312-319.
34. Takahashi, N., K. I. Morishige, A. Jahangir, M. Yamada, I. Findlay, H. Koyama, and Y. Kurachi. 1994. Molecular cloning and functional expression of cDNA encoding a second class of inward rectifier potassium channels in the mouse brain. J. Biol. Chem. 269:23274-23279.
35. Walkey, C. J., L. R. Donohue, R. Bronson, L. B. Agellon, and D. E. Vance. 1997. Disruption of the murine gene encoding phosphatidylethanolamine N-methyltransferase. Proc. Natl. Acad. Sci. USA 94:12880-12885.
36. Yan, M., H. Wang, B. Chan, M. Roose-Girma, S. Erickson, T. Baker, D. Tumas, I. S. Grewal, and V. M. Dixit. 2001. Activation and accumulation of B cells in TACI-deficient mice. Nat. Immunol. 2:638-643.
37. Yu, Y., and A. Bradley. 2001. Engineering chromosomal rearrangements in mice. Nat. Rev. Genet. 10:780-790.
38. Zhao, Q., K.-S. Chen, B. A. Bejjani, and J. R. Lupski. 1998. Cloning, genomic structure and expression of mouse ringer finger protein gene Znf179. Genomics 49:394-400.
39. Zheng, B., A. A. Mills, and A. Bradley. 1999. A system for rapid generation of coat color-tagged knockouts and defined chromosomal rearrangements in mice. Nucleic Acids Res. 27:2354-2360.